| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,¶,¶
,¶
*
Department of Immunology and
Technical Support Laboratory, Medical Institute of Bioregulation,
Kyushu University, Fukuoka, Japan; and
Amgen Institute and
¶
Ontario Cancer Institute and Departments of Medical Biophysics and Immunology, University of Toronto, Ontario, Canada
Negative selection is a process to delete potentially autoreactive clones in developing thymocytes. Programmed cell death or apoptosis is thought to play an important role in this selection process. In this study, we investigated the role of apoptotic protease-activating factor 1 (Apaf1), a mammalian homologue of CED-4, in programmed cell death during the negative selection in thymus. There was no developmental abnormality in thymocytes from newborn Apaf1-/- mice in terms of CD4 and CD8 expression pattern and thymocyte number. Clonal deletion by endogenous male H-Y Ag of Apaf1-deficient thymocytes with transgenic expression of H-Y Ag-specific TCRs (H-Y Tg/Apaf1-/- thymocytes) was normally observed in lethally irradiated wild-type mice reconstituted with fetal liver-derived hemopoietic stem cells. Clonal deletion induced in vitro by a bacterial superantigen was also normal in fetal thymic organ culture. Thus, Apaf1-mediated pathway of apoptosis is dispensable for the negative selection of thymocytes. However, H-Y Tg/Apaf1-/- thymocytes showed partial resistance to H-Y peptide-induced deletion in vitro as compared with H-Y Tg/Apaf1+/- thymocytes, implicating the Apaf1-mediated apoptotic pathway in the negative selection in a certain situation. In addition, the peptide-induced deletion was still observed in H-Y Tg/Apaf1-/- thymocytes in the presence of a broad spectrum caspase inhibitor, z-VAD-fmk, suggesting the presence of caspase-independent cell death pathway playing roles during the negative selection. We assume that mechanisms for the negative selection are composed of several cell death pathways to avoid failure of elimination of autoreactive clones.
This article has been cited by other articles:
|
|
 |
|
  S. Ramanathan, J. Gagnon, C. Leblanc, R. Rottapel, and S. Ilangumaran Suppressor of Cytokine Signaling 1 Stringently Regulates Distinct Functions of IL-7 and IL-15 In Vivo during T Lymphocyte Development and Homeostasis J. Immunol., April 1, 2006; 176(7): 4029 - 4041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Villunger, V. S. Marsden, Y. Zhan, M. Erlacher, A. M. Lew, P. Bouillet, S. Berzins, D. I. Godfrey, W. R. Heath, and A. Strasser Negative selection of semimature CD4+8-HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling PNAS, May 4, 2004; 101(18): 7052 - 7057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Adams Ways of dying: multiple pathways to apoptosis Genes & Dev., October 15, 2003; 17(20): 2481 - 2495. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Schmitz, L. K. Clayton, and E. L. Reinherz Gene expression analysis of thymocyte selection in vivo Int. Immunol., October 1, 2003; 15(10): 1237 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. O. Kim, K. Ono, P. S. Tobias, and J. Han Orphan Nuclear Receptor Nur77 Is Involved in Caspase-independent Macrophage Cell Death J. Exp. Med., June 2, 2003; 197(11): 1441 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cande, F. Cecconi, P. Dessen, and G. Kroemer Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell Sci., March 14, 2003; 115(24): 4727 - 4734. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
